Miniature market Target mid-market hospitals and private surgical centers in orthopedics, ENT, spine, urology, and gynecology where ArthroCare’s Coblation and OPUS fixation technologies can expand minimally invasive procedures, offering a clear upsell from traditional devices.

Coblation advantage Emphasize the precision tissue dissolution and reduced collateral damage of Coblation technology to differentiate offerings from competitors, positioning as a value driver for faster recoveries and improved patient outcomes.

IP leverage Highlight IP position and ongoing patent landscape challenges in marketing materials to reassure buyers about long-term device availability and defend against competitive disruptions.

Strategic partnerships Explore co-development or bundled offerings with larger OEMs or distributors in the surgical devices space to scale reach, leveraging ArthroCare’s comprehensive product lines across multiple specialties.

Global expansion Identify opportunities to enter international markets where minimally invasive surgical trends are growing, aided by scalable cloud and device technology platforms to support adoption and after-sales service.